Ross et al.[33] recently reported that TO-207/JTE-607 could bind to CPSF3, inhibiting the proliferation of acute myelogenous leukemia and Ewing’s sarcoma cell lines by suppressing the aberrant expression of downstream oncogenic pathways. Here, CPSF3 is linked to Ewing sarcoma.